Logo

BioChain Institute: NGS-Characterized Bio-Samples for Oncology Research

Sep 24, 2021

BioChain Institute has expanded its line of next generation sequencing-characterized bio-samples, to be used in preclinical drug development and as reference samples in CLIA labs. It now offers tissue samples characterized for BRCA1, BRCA2, MSI, HPV, EGFR, and KRAS and is developing additional mutation-specific samples. All samples are available in frozen and formalin-fixed paraffin-embedded formats, and some come as matched sets including normal tissue and adjacent primary tumor tissue as well as plasma from the same donor.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.